These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16865593)

  • 1. Borderline resectable pancreatic cancer: a new classification for an old challenge.
    Talamonti M
    Ann Surg Oncol; 2006 Aug; 13(8):1019-20. PubMed ID: 16865593
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining venous involvement in borderline resectable pancreatic cancer.
    Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
    Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
    Schwarz L; Katz MH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.
    Varadhachary GR; Tamm EP; Abbruzzese JL; Xiong HQ; Crane CH; Wang H; Lee JE; Pisters PW; Evans DB; Wolff RA
    Ann Surg Oncol; 2006 Aug; 13(8):1035-46. PubMed ID: 16865597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
    Evans DB; Erickson BA; Ritch P
    Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
    [No Abstract]   [Full Text] [Related]  

  • 6. How to define and manage borderline resectable pancreatic cancer.
    Papavasiliou P; Chun YS; Hoffman JP
    Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the management of borderline resectable pancreatic cancer.
    Sharma J; Ng J; Goodman MD; Saif MW
    JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Borderline resectable pancreatic cancer: ISGPS consensus statement].
    Strobel O; Büchler MW;
    Chirurg; 2014 Nov; 85(11):1014. PubMed ID: 25385138
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT.
    O'Malley ME; Boland GW; Wood BJ; Fernandez-del Castillo C; Warshaw AL; Mueller PR
    AJR Am J Roentgenol; 1999 Dec; 173(6):1513-8. PubMed ID: 10584794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant therapy may allow unresectable tumors becoming resectable].
    Sa Cunha A
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S113-6. PubMed ID: 26118869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic adenocarcinoma.
    Stephens DH
    Abdom Imaging; 1996; 21(3):207-10. PubMed ID: 8661549
    [No Abstract]   [Full Text] [Related]  

  • 13. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
    Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma of the pancreas: current status of multimodal therapy].
    Keck T
    Zentralbl Chir; 2011 Aug; 136(4):352-8. PubMed ID: 21773958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of pancreatic and ampullary cancer.
    Murr MM; Oishi AJ; Toma TP; Sarr MG
    J Med Liban; 1995; 43(4):200-7. PubMed ID: 8885553
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
    Kang CM; Hwang HK; Choi SH; Lee WJ
    Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline resectable pancreatic cancer. Challenges and controversies.
    Sabater L; Muñoz E; Roselló S; Dorcaratto D; Garcés-Albir M; Huerta M; Roda D; Gómez-Mateo MC; Ferrández-Izquierdo A; Darder A; Cervantes A
    Cancer Treat Rev; 2018 Jul; 68():124-135. PubMed ID: 29957372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to 'borderline resectable' pancreatic tumors.
    Varadhachary GR; Abbruzzese JL
    Oncology (Williston Park); 2008 Nov; 22(13):1529-30. PubMed ID: 19227575
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
    Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
    Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.